VE-465
VE-465 is an Aurora kinase inhibitor. VE-465 induces cancer cell apoptosis. VE-465 has anticancer effects in multiple tumor models[1][2].
Product Specifications
CAS Number
639089-73-9
UNSPSC
12352005
Target
Aurora Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ve-465.html
Solubility
10 mM in DMSO
Smiles
CCC(NC1=CC=C(C=C1)SC2=NC(NC3=NNC(C)=C3)=CC(N4CCN(CC4)C)=N2)=O
Molecular Formula
C22H28N8OS
Molecular Weight
452.58
References & Citations
[1]Lin ZZ, et al. The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. J Hepatol. 2009 Mar;50 (3) :518-27.|[2]Evans R, et al. Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells. Leuk Lymphoma. 2008 Mar;49 (3) :559-69.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1135784-01 0.02 mg (E-Coli)
Recombinant Desulfovibrio vulgaris subsp. vulgaris ATP synthase epsilon chain (atpC)
Sign In for Pricing
View Details MBS1135784-02 0.1 mg (E-Coli)
Recombinant Desulfovibrio vulgaris subsp. vulgaris ATP synthase epsilon chain (atpC)
Sign In for Pricing
View Details MBS1135784-03 0.02 mg (Yeast)
Recombinant Desulfovibrio vulgaris subsp. vulgaris ATP synthase epsilon chain (atpC)
Sign In for Pricing
View Details MBS1135784-04 0.1 mg (Yeast)
Recombinant Desulfovibrio vulgaris subsp. vulgaris ATP synthase epsilon chain (atpC)
Sign In for Pricing
View Details MBS1135784-05 0.02 mg (Baculovirus)
Recombinant Desulfovibrio vulgaris subsp. vulgaris ATP synthase epsilon chain (atpC)
Sign In for Pricing
View Details MBS1135784-06 0.02 mg (Mammalian-Cell)
Recombinant Desulfovibrio vulgaris subsp. vulgaris ATP synthase epsilon chain (atpC)
Sign In for Pricing
View Details